Prosecution Insights
Last updated: May 29, 2026

UTI LIMITED PARTNERSHIP

5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days

Portfolio Summary

5
Total Pending OAs
4
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (20%)
3
Medium (60%)
0
Easy (0%)
1
Unknown (20%)

Rejection Statute Mix

BucketCases
§101 only1 (20%)
§103 only3 (60%)
No statute on record1 (20%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
80% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
20% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NGUYEN, CHUONG P 1 78.8% +13.4%
GONZALEZ, LUISALBERTO 1 61.4% +47.4%
HOU, FRANK S 1 71.5% +34.5%
JOHNSON, CHRISTOPHER LINDSAY 1 54.2% +73.3%
SABILA, MERCY HELLEN 1 58.7% +45.4%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18646965 SATELLITE NAVIGATION ACCELEROMETER NGUYEN, CHUONG P 28d

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18026397 METHODS OF TREATING AND/OR PREVENTING ALZHEIMER’S DISEASE WITH R-CARVEDILOL JOHNSON, CHRISTOPHER LINDSAY 66d overdue
18581095 Halogenated Xanthenes as Vaccine Adjuvants GONZALEZ, LUISALBERTO 19d overdue
17532578 NANOPARTICLES COMPRISING NON-CLASSICAL MHC AND USES THEREOF SABILA, MERCY HELLEN 19d overdue
18273312 CHROMIUM PHOSPHONATE METAL-ORGANIC FRAMEWORKS, PROCESS FOR PREPARING THE SAME AND USES THEREOF HOU, FRANK S 21d
18646965 SATELLITE NAVIGATION ACCELEROMETER NGUYEN, CHUONG P 28d

Top Art Units

Art UnitApps
3646 1
1624 1
1692 1
1691 1
1654 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18646965 SATELLITE NAVIGATION ACCELEROMETER NGUYEN, CHUONG P 3646 §101 Non-Final OA 28d Pending Apr 26, 2024
18581095 Halogenated Xanthenes as Vaccine Adjuvants GONZALEZ, LUISALBERTO 1624 Other Final Rejection 19d overdue Pending Feb 19, 2024
18273312 CHROMIUM PHOSPHONATE METAL-ORGANIC FRAMEWORKS, PROCESS FOR PREPARING THE SAME AND USES THEREOF HOU, FRANK S 1692 §103 Non-Final OA 21d Pending Jul 20, 2023
18026397 METHODS OF TREATING AND/OR PREVENTING ALZHEIMER’S DISEASE WITH R-CARVEDILOL JOHNSON, CHRISTOPHER LINDSAY 1691 §103 Non-Final OA 66d overdue Pending Mar 15, 2023
17532578 NANOPARTICLES COMPRISING NON-CLASSICAL MHC AND USES THEREOF SABILA, MERCY HELLEN 1654 §103 Non-Final OA 19d overdue Pending Nov 22, 2021

Managing UTI LIMITED PARTNERSHIP's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month